In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
CompoSecure Announces CFO Retirement; Reaffirms Previously Issued Full Year 2025 Guidance CompoSecure announces that Tim Fitzsimmons, its Chief Financial Officer, will retire from his position once a successor has been named and assumes the role, which is anticipated to occur in the second half of 2025, but no later than January 1, 2026.A comprehensive search will be launched for a CFO successor; Mr. Fitzsimmons will serve as a consultant commencing on his retirement date and through January 1, 2027 to ensure a smooth transition.CompoSecure reaffirms its previously issued full year 2025 gui...
Treace Files Patent Infringement Suit Against Zimmer Biomet to Protect Lapiplasty® Bunion Technology PONTE VEDRA, Fla., June 05, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship and procedures, today announced that it filed a lawsuit against Zimmer Biomet Holdings, Inc. and Paragon 28, Inc. (collectively, “Zimmer”) (NYSE: ZBH), alleging infringement of 4 patents related to Treace’s innovativ...
CompoSecure Reports First Quarter 2025 Financial Results Operating results in line with expectationsReiterating previously issued full-year 2025 guidanceCompleted spin-off of Resolute Holdings Management, Inc. (Nasdaq: RHLD)Accounting standards related to the spin-off require the Company to report results using equity method of accounting in accordance with U.S. GAAPNon-GAAP results are also included below and provide a clearer picture of the underlying financial performance of the operating business consistent with historical reporting SOMERSET, N.J., May 12, 2025 (GLOBE NEWSWIR...
Treace Medical Concepts Reports First Quarter 2025 Financial Results PONTE VEDRA, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship and Procedures, today reported financial results for the first quarter ended March 31, 2025. Recent Highlights Generated revenue of $52.6 million in first quarter 2025 representing growth of 3% over the same period in 2024.Improved first quarter 2...
CompoSecure Schedules First Quarter 2025 Conference Call for May 12th at 5:00 p.m. ET SOMERSET, N.J., April 29, 2025 (GLOBE NEWSWIRE) -- . (Nasdaq: CMPO), a leader in metal payment cards, security, and authentication solutions, will host a conference call on Monday, May 12, 2025, at 5:00 p.m. Eastern Daylight Time (EDT) to discuss its financial results for the first quarter ended March 31, 2025. The Company’s results will be reported in a press release prior to the call. CompoSecure’s management will host the conference call, followed by a question-and-answer period. Date: Monday, May 1...
New MetaMask Metal Payment Card: Self-Custody Crypto Card With Direct Payments Unveiled by CompoSecure, Baanx and MetaMask A simple, secure, and direct way to spend crypto directly from MetaMask, one of the world’s leading self-custody wallet providers SOMERSET, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- , a leader in metal payment cards, security, and authentication solutions, in collaboration with Baanx and MetaMask, today announced the launch of the MetaMask metal payment card. The new cutting-edge payment solution bridges the gap between self-custody crypto and real-world spending. Th...
Treace to Report First Quarter 2025 Financial Results on May 8, 2025 PONTE VEDRA, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship and Procedures, today announced that it will release financial results for the first quarter 2025 after the close of trading on Thursday, May 8, 2025. Company management will host a conference call to discuss financial results beginning at 4:30 pm...
CompoSecure Integrates Arculus with MoneyGram: Becomes First Hardware Wallet to Provide Global Cash In/Cash Out Through Stellar SOMERSET, N.J., April 21, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: CMPO), a leader in metal payment cards, security, and authentication solutions, today announced the integration of its Arculus Cold Storage Wallet with MoneyGram Access™, which enables users to add and withdraw USDC in cash at participating MoneyGram locations. Arculus is the first hardware wallet to integrate with MoneyGram Access, enabling consumers to seamlessly convert physical cash into Circle USD...
CompoSecure Global Survey Supports Metal Payment Cards as a Powerful Tool for Banks and Fintechs to Attract, Engage, and Retain High-Value Customers 68% of cardholders would select a bank card program over another if it offered a metal payment card66% of ultra-high-net-worth respondents would use metal payment cards more than other cards in their wallet69% of successful young individuals would stay with a bank offering a metal payment card 73% of cardholders would pay extra for a metal payment cardBanks issuing a metal card are seen as innovative 74%, environmentally conscious 70%, prestigi...
Treace Announces Upcoming Board Chair Transition PONTE VEDRA, Fla., April 07, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship and Procedures, today announced that its Board of Directors has appointed John. T. Treace, Chief Executive Officer and Founder of Treace, as the Chairman of the Board to be effective immediately following the 2025 annual meeting of stockholders. Mr. John. T. Treace w...
Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty® and Adductoplasty® Outcomes at the 2025 ACFAS Annual Scientific Conference PONTE VEDRA, Fla., March 28, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship and Procedures, today announced the presentation of updated interim data for the ALIGN3D™ and Mini3D™ Lapiplasty® clinical studies, as well as the first presentation of ...
Treace Highlights New Innovations at the 2025 ACFAS Annual Scientific Conference Expands market-leading position with new best-in-class bunion technologies PONTE VEDRA, Fla., March 25, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship and Procedures, today announced new technology innovations featured at the 2025 American College of Foot and Ankle Surgeons (“ACFAS”) Annual Scientific Confer...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.